PTCH1 and endometrial cancer: Here, we report a 2.3–5.85 % prevalence of mutations in the PTCH1 CTD in the stomach, colorectal and endometrial cancers, with three frequent frameshift spots that result in truncation of the wild-type sequence after S1203, R1308 and Y1316.